Balance App

What Balance App does

Balance App, operated by Newson Health Limited, is a UK-based mobile health application providing evidence-based hormone health content and symptom tracking for women across multiple life stages, including PMS, PMDD, postnatal depression, endometriosis, PCOS, perimenopause, and menopause. The platform delivers personalized content authored by founder Dr. Louise Newson and her medical team, with all material medically reviewed and produced independently of pharmaceutical company input. The product is distributed globally through the Apple App Store and Google Play Store under a freemium model, with a core free tier and a Balance+ premium subscription offering enhanced features. Underlying technology is a mobile content and tracking platform rather than an AI-driven system; no AI/ML capabilities, APIs, or integrations are disclosed.

The company has achieved meaningful third-party validation, including Apple's Editors' Choice and App of the Day awards, ORCHA certification as the first menopause support app approved by the leading NHS-referenced digital health reviewer, and a 4.8-star App Store rating. Reported user engagement is substantial at 132 million logged hormone symptoms, though specific user counts, retention, and revenue figures are not publicly disclosed. The product sits within an addressable market projected to grow from $1.2 billion in 2024 to $5.1 billion by 2033 at an 18.7% CAGR.

The business model is freemium consumer subscription, distributed product-led through app stores and supported by a multi-channel marketing approach spanning evidence-based content, a supportive user community, the Dr. Louise Newson newsletter and podcast, social media, and word-of-mouth referrals, with users reportedly recommending the app to 25 or more friends. The company reports a lean headcount of 1-10 employees, is founder-controlled, and has not disclosed any external funding rounds, suggesting operations are funded by founders or operating cash flow. The Newson Clinic, the founder's medical practice, serves as the clinical and content backbone for the app.

Name

Balance App

Legal name

Newson Health Limited

Website

https://balance-menopause.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Balance App, by UK's Newson Health Limited, is a mobile application providing evidence-based hormone health content and symptom tracking for women across PMS, PMDD, endometriosis, PCOS, perimenopause, and menopause, distributed globally via freemium with a Balance+ premium tier.

Ownership category

akta.pro rank

Headquarters

HQ city

Manchester

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Freemium App with Premium Balance+ Tier: The Balance app is available as a free download with core features including symptom tracking, evidence-based resources, and community access. A premium Balance+ tier offers enhanced features for subscribers. Revenue is generated through subscription-based freemium model.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

Balance App is a free mobile application that provides evidence-based, personalized hormone health content covering PMS, PMDD, postnatal depression, endometriosis, PCOS, perimenopause, and menopause, combined with symptom tracking, educational resources, and a supportive community for women. A premium Balance+ subscription tier unlocks enhanced features on a monthly billing basis. All content is medically reviewed, written by Dr. Louise Newson and her team, and produced independently of any pharmaceutical company input.

Product overview

Balance App is a single-platform mobile application focused on hormone health education and tracking. The core product, Balance App, serves as a symptom tracking and educational resource for women experiencing hormonal changes across various life stages. A premium tier called Balance+ offers enhanced features. The platform provides evidence-based content written by medical professionals and connects users with the broader Balance ecosystem including the Dr Louise Newson podcast and Newson Clinic services.

Differentiator

Problem solved

Functional benefit

Products and services

• Balance App Free mobile application providing evidence-based, personalized hormone health content covering PMS, PMDD, postnatal depression, endometriosis, PCOS, perimenopause, and menopause, with symptom tracking, educational resources, and a supportive community for women experiencing hormonal changes.
• Balance+ Premium subscription tier of the Balance app offering enhanced features and additional content beyond the free core offering, billed monthly.

Quantifiable outcome

• 132 Million hormone symptoms logged by users
• +1 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Newson CliniccoreOthersNewson Clinic is the medical practice founded by Dr. Louise Newson, the founder of Balance App. Dr. Newson is a physician and women's hormone specialist who has contributed to peer-reviewed publications. The clinic represents the clinical foundation behind the app's evidence-based approach.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Evernow: Evernow provides telehealth care, prescriptions, and education for women in perimenopause and menopause. It overlaps directly with Balance's audience and value proposition, with a heavier emphasis on clinical/prescription services.
• Maven Clinic: Maven Clinic is a virtual women's and family health platform covering fertility, pregnancy, postpartum, and menopause. Its menopause/midlife women's health offering directly overlaps with Balance App, though it spans a broader women's health lifecycle.
• Carrot Fertility: Carrot provides fertility, hormonal health, and menopause benefits to employers and individuals. Its menopause offering overlaps with Balance's audience and value proposition, with a strong employer-sponsored go-to-market.
• Midi Health: Midi Health is a virtual care clinic focused on women's midlife hormonal health, including perimenopause and menopause. It offers telehealth consultations, prescriptions, and ongoing care, making it a direct competitor to Balance App in the women's hormone health category, with deeper clinical services.
• Elektra Health: Elektra Health is a digital menopause care platform combining evidence-based education, virtual care, and community. Like Balance, it is purpose-built for menopause and hormone health, targeting the same audience with both content and clinical services.
• Gennev: Gennev (now part of Unified Women's Healthcare) provides menopause-focused telehealth, education, and community. It competes with Balance in the US women's midlife health space, with an overlapping content-plus-clinical model.
• Bonafide Health: Bonafide Health is a women's health company offering evidence-based, non-prescription products and education for menopause and hormonal health. It targets a similar audience as Balance with a product-and-content hybrid model.

Regional players

• Peppy Health: Peppy Health is a UK-based digital health platform offering employer-sponsored support for menopause, fertility, and other conditions. It is a UK regional peer to Balance, with similar employer/B2B distribution and menopause focus.

Emerging players

• Stella (menopause mental health): Stella is a digital mental health platform focused on menopause and midlife women's mental health. It overlaps with Balance's content/community layer for menopause, with a narrower focus on the mental health subset of symptoms.
• Oura: Oura is a consumer wearable and app focused on health tracking (sleep, cycle, readiness). While not menopause-specific, its cycle/insight features intersect with Balance's symptom tracking use case and audience (women's health).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/balanceMeno
• Facebookfacebook.com/balanceMenopause
• LinkedInlinkedin.com/company/balance-app

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Balance App